(Q40821289)

24 September 2017

A phase I trial of recombinant gamma interferon in patients with cancer (English)

1 reference

24 September 2017

phase I clinical trial

0 references

author name string

K A Foon

1

1 reference

24 September 2017

S A Sherwin

2

1 reference

24 September 2017

P G Abrams

3

1 reference

24 September 2017

H C Stevenson

4

1 reference

24 September 2017

P Holmes

5

1 reference

24 September 2017

A E Maluish

6

1 reference

24 September 2017

R K Oldham

7

1 reference

24 September 2017

R B Herberman

8

1 reference

24 September 2017

1 January 1985

1 reference

Cancer Immunology, Immunotherapy

24 September 2017

1 reference

24 September 2017

20

1 reference

24 September 2017

193-197

1 reference

24 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00205575

24 September 2017

0 references

cites work

Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's Lymphoma

1 reference

12 December 2020

Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells

1 reference

12 December 2020

Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon

1 reference

12 December 2020

Recombinant interferon-gamma increases HLA-DR synthesis and expression

1 reference

12 December 2020

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma

1 reference

12 December 2020

Structure of the human immune interferon gene

1 reference

12 December 2020

Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself

1 reference

12 December 2020

Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma

1 reference

12 December 2020

Increased monocyte-mediated cytostasis of lymphoid cell lines in breast and lung cancer patients

1 reference

12 December 2020

A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer

1 reference

12 December 2020

A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients

1 reference

12 December 2020

Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients

1 reference

12 December 2020

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

1 reference

12 December 2020

Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation

1 reference

12 December 2020

Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial

1 reference

12 December 2020

Functional identity between murine γ Interferon and macrophage activating factor

1 reference

12 December 2020

Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia

1 reference

12 December 2020

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

12 December 2020

Evidence that types I and II interferons have different receptors

1 reference

12 December 2020

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

1 reference

12 December 2020

Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma

1 reference

12 December 2020

Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes

1 reference

12 December 2020

Pharmacokinetic study of partially pure gamma-interferon in cancer patients

1 reference

12 December 2020

Alpha interferon for induction of remission in hairy-cell leukemia

1 reference

12 December 2020

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

1 reference

12 December 2020

Interferon therapy in myelomatosis

1 reference

12 December 2020

Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant Lymphoma

1 reference

12 December 2020

Enhanced expression of HLA antigens and β2-microglobulin on interferon-treated human lymphoid cells

1 reference

12 December 2020

Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205575

1 reference

Dimensions Publication ID

24 September 2017

0 references

1 reference